- $150 - 1200
- prospecbio
- PRV-003
- 以色列
- 2025年07月14日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
大量
- 英文名：
Parvovirus VLP VP1 Recombinant
- 保质期：
1年
- 供应商：
上海沪震实业有限公司
- 保存条件：
-20°C
- 规格：
100μg/500μg/1mg
CATALOGUE NUMBER
PRV-003
INTRODUCTION
The B19 virus, usually referred to as parvovirus B19 or sometimes as erythrovirus B19, belongs to the family of parvoviruses, genus erythrovirus. B19 virus causes a childhood rash named “fifth disease” or “erythema infectiosum” which is ordinarily known as “slapped cheek syndrome”. Erythroviruses are members of the Parvoviridae family of small DNA viruses. The B19 virus is a non-enveloped, icosahedral virus which contains a single-stranded linear DNA genome. Parvovirus B19 is classified as erythrovirus because of its capability to invade red blood cell precursors in the bone marrow. This virus is mainly spread by infected respiratory droplets; though, blood-borne transmission has also been reported.DESCRIPTION
Recombinant Parvovirus B19 VLP VP1 produced in e.coli contains 227 amino acids from the N-terminus of VP1 protein sequence.Parvovirus B19 VLP VP1/VP2 is purified by proprietary chromatographic techniques.
SOURCE
e.coli.PHYSICAL APPEARANCE
Sterile Filtered clear solution.FORMULATION
Parvovirus B19 VLP VP1 protein solution is supplied in PBS pH 7.4 and 0.02% Sodium azide.STABILITY
Store at 4°C if entire vial will be used within 2-4 weeks.Store, frozen at -20°C for longer periods of time.
Avoid multiple freeze-thaw cycles.
PURITY
Greater than 90.0% as determined by 12% PAGE (coomassie staining).USAGE
ProSpec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Diagnosis of Parvovirus B19-DNA by Dot-Blot Hybridization
Parvovirus B 19 was discovered at the Virus Reference Laboratory in 1975 by Cossart and colleagues (1 ). First found in healthy blood donors, parvovirus B19 infection usually manifests as erythema infectiosum (fifth disease) in children
The JC Virus-Like Particle Overlay Assay
, and a virus-like particle (VLP) consisting of recombinant VP1 made from Escherichia coli exhibit a virion-like structure and physiological functions (cellular attachment and intracytoplasmic trafficking) similar to those of JCV virions. To examine
Generation of Recombinant Adeno-Associated Virus
as a potential vector for gene therapy. For example, AAV is not pathogenic, approx 80% of adults in the United States are seropositive, but in no case has the virus been implicated as the etiological agent for a human disease. AAV is a defective parvovirus
技术资料暂无技术资料 索取技术资料
